SAN DIEGO (AP) _ Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $8.1 million in its fourth quarter.The San Diego-based company said it had a loss of 16 cents per share.The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.The biopharmaceutical company posted revenue of $556,000 in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $2 million.For the year, the company reported a loss of $31.3 million, or 64 cents per share. Revenue was reported as $4.3 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT